Meta AnalysisID 4377
丹参酮IIA治疗慢性充血性心力衰竭的疗效及安全性
CRD42022380193
To explore the efficacy and safety of tanshinone IIA in the treatment of chronic congestive heart failure
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 4377
- Evidence Id
- 12935
- Core Evidence Id
- 12935
- Source Meta Analysis Id
- 4345
- Herb2 Meta Analysis Id
- HBMA004345
- Crd Id
- CRD42022380193
- Title
- Efficacy and safety of tanshinone IIA in the treatment of chronic congestive heart failure
- Review Question
- To explore the efficacy and safety of tanshinone IIA in the treatment of chronic congestive heart failure
- Study Type Included
- Randomized controlled trials will be included to evaluate tanshinone IIA in the treatment of chronic congestive heart failure.
- Condition Being Studied
- tanshinone IIA chronic congestive heart failure
- Participant
- (1)randomized controlled trials (RCTs); (2) participants with specified diagnosis criteria of chronic congestive heart failure; (3) interventional therapies was Tanshinone IIA ; (4)control therapies included blank, placebo, and western medicine.
- Animal
- Human Disease Modelled
- Intervention
- Intervention included Tanshinone IIA , no limit to dosage form, frequency and dosage. And intervention could be only Tanshinone IIA , Tanshinone IIA plus Western medicine.
- Comparator Control
- Control included blank, placebo, Western medicin.
- Main Outcome
- left ventricular ejection Fraction (LVEF) Measures of effect Measurement data
- Outcome Measure
- Additional Outcome
- Left ventricular end-diastolic Diameter (LVDD), left cardiac output (CO), left ventricular end-systolic diameter (LVSD) Measures of effect Measurement data
- Study Method
- Systematic review
- Keyword
- Abietanes; Heart Failure; Humans; tanshinone
- Contact
- Yiwei Qu [email protected]
- Organisational Affiliation
- Shandong University of Traditional Chinese Medicine
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-11-29
- Registration Date
- 2022-12-10
- Anticipated Start Date
- 2022-12-01
- Anticipated Completion Date
- 2023-02-28
- Title Cn
- 丹参酮IIA治疗慢性充血性心力衰竭的疗效及安全性
- Title En
- Efficacy and safety of tanshinone IIA in the treatment of chronic congestive heart failure
- Bilingual Status
- complete